| Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial AL Zietman, ML DeSilvio, JD Slater, CJ Rossi, DW Miller, JA Adams, ... Jama 294 (10), 1233-1239, 2005 | 1565 | 2005 |
| Early detection of prostate cancer: AUA Guideline HB Carter, PC Albertsen, MJ Barry, R Etzioni, SJ Freedland, KL Greene, ... The Journal of urology 190 (2), 419-426, 2013 | 1407 | 2013 |
| Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation … AL Zietman, K Bae, JD Slater, WU Shipley, JA Efstathiou, JJ Coen, ... Journal of clinical oncology 28 (7), 1106, 2010 | 900 | 2010 |
| Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline SS Chang, BH Bochner, R Chou, R Dreicer, AM Kamat, SP Lerner, ... The Journal of urology 198 (3), 552-559, 2017 | 848 | 2017 |
| Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer MR Smith, FJ McGovern, AL Zietman, MA Fallon, DL Hayden, ... New England Journal of Medicine 345 (13), 948-955, 2001 | 846 | 2001 |
| Changes in body composition during androgen deprivation therapy for prostate cancer MR Smith, JS Finkelstein, FJ McGovern, AL Zietman, MA Fallon, ... The Journal of Clinical Endocrinology & Metabolism 87 (2), 599-603, 2002 | 800 | 2002 |
| Prostate specific antigen best practice statement: 2009 update KL Greene, PC Albertsen, RJ Babaian, HB Carter, PH Gann, M Han, ... The Journal of urology 189 (1), S2-S11, 2013 | 702 | 2013 |
| Radiation with or without antiandrogen therapy in recurrent prostate cancer WU Shipley, W Seiferheld, HR Lukka, PP Major, NM Heney, DJ Grignon, ... New England Journal of Medicine 376 (5), 417-428, 2017 | 621 | 2017 |
| Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results … P Grimm, I Billiet, D Bostwick, AP Dicker, S Frank, J Immerzeel, M Keyes, ... BJU international 109, 22-29, 2012 | 575 | 2012 |
| Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation MJ Zelefsky, DA Kuban, LB Levy, L Potters, DC Beyer, JC Blasko, ... International Journal of Radiation Oncology* Biology* Physics 67 (2), 327-333, 2007 | 569 | 2007 |
| Outcomes of localized prostate cancer following conservative management GL Lu-Yao, PC Albertsen, DF Moore, W Shih, Y Lin, RS DiPaola, MJ Barry, ... Jama 302 (11), 1202-1209, 2009 | 550 | 2009 |
| Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis WU Shipley, HD Thames, HM Sandler, GE Hanks, AL Zietman, CA Perez, ... Jama 281 (17), 1598-1604, 1999 | 549 | 1999 |
| Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas HA Gay, HJ Barthold, E O’Meara, WR Bosch, I El Naqa, R Al-Lozi, ... International Journal of Radiation Oncology* Biology* Physics 83 (3), e353-e362, 2012 | 539 | 2012 |
| American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy BJ Davis, EM Horwitz, WR Lee, JM Crook, RG Stock, GS Merrick, ... Brachytherapy 11 (1), 6-19, 2012 | 509 | 2012 |
| Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer FJ Fowler Jr, MMN Collins, PC Albertsen, A Zietman, DB Elliott, MJ Barry Jama 283 (24), 3217-3222, 2000 | 503 | 2000 |
| Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation … WU Shipley, LJ Verhey, JE Munzenrider, HD Suit, MM Urie, PL McManus, ... International Journal of Radiation Oncology* Biology* Physics 32 (1), 3-12, 1995 | 499 | 1995 |
| Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience JA Efstathiou, DY Spiegel, WU Shipley, NM Heney, DS Kaufman, ... European urology 61 (4), 705-711, 2012 | 485 | 2012 |
| Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer WU Shipley, DS Kaufman, E Zehr, NM Heney, SC Lane, HK Thakral, ... Urology 60 (1), 62-67, 2002 | 459 | 2002 |
| Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology … RH Mak, D Hunt, WU Shipley, JA Efstathiou, WJ Tester, MP Hagan, ... Journal of Clinical Oncology 32 (34), 3801, 2014 | 448 | 2014 |
| Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer JM Michalski, C Lawton, I El Naqa, M Ritter, E O'Meara, MJ Seider, ... International Journal of Radiation Oncology* Biology* Physics 76 (2), 361-368, 2010 | 410 | 2010 |
